Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
2.8%
% of VHT's 415 holdings also in OZEM
52.4%
% of OZEM's 22 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.0% | 16.9% | 12.0% |
|
AMGEN INC | 2.6% | 3.0% | 2.6% |
|
PFIZER INC | 2.2% | 3.5% | 2.2% |
|
GILEAD SCIENCES INC | 2.3% | 1.8% | 1.8% |
|
REGENERON PHARMACEUTICALS | 1.1% | 2.3% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 7.4% |
|
JOHNSON & JOHNSON | 5.0% |
|
ABBVIE INC | 4.9% |
|
ABBOTT LABORATORIES | 4.0% |
|
MERCK & CO. INC. | 3.3% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
THERMO FISHER SCIENTIFIC INC | 2.9% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
|
DANAHER CORP | 2.1% |
VHT Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -16.2% |
 |
ROCHE HOLDING LTD | -4.9% |
|
ELI LILLY & CO | -4.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
ZEALAND PHARMA A/S | -4.6% |
|
VIKING THERAPEUTICS, INC. | -4.1% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
|
ALTIMMUNE, INC. | -3.6% |
 |
HANMI PHARM CO LTD | -3.1% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.1% |